clinical cancer research table of...
TRANSCRIPT
SPECIAL FEATURES
Highlights of This Issue 251
CCR Translations
253 Targeting CDH17 in Cancer: When Blocking theLigand Beats Blocking the Receptor?John F. MarshallSee related article, p. 433
256 Drug Repositioning Meets Precision inGlioblastomaWolfgang Wick and Tobias KesslerSee related article, p. 295
Reviews
259 Toward Precision Radiotherapy for Use withImmune Checkpoint BlockersClaire Vanpouille-Box, Silvia C. Formenti, andSandra Demaria
266 Tumor-Treating Fields: A Fourth Modality inCancer TreatmentElijah J. Mun, Hani M. Babiker, Uri Weinberg,Eilon D. Kirson, and Daniel D. Von Hoff
CANCER THERAPY: CLINICAL
276 Clinical and Immunologic Biomarkers forHistologic Regression of High-Grade CervicalDysplasia and Clearance of HPV16 and HPV18after ImmunotherapyMatthew P. Morrow, Kimberly A. Kraynyak,Albert J. Sylvester, Michael Dallas, Dawson Knoblock,Jean D. Boyer, Jian Yan, Russell Vang, Amir S. Khan,Laurent Humeau, Niranjan Y. Sardesai, J. Joseph Kim,Stanley Plotkin, David B. Weiner, Cornelia L. Trimble, andMark L. Bagarazzi
295 Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and ProgressiveGlioblastomaSara A. Byron, Nhan L. Tran, Rebecca F. Halperin,Joanna J. Phillips, John G. Kuhn, John F. de Groot,Howard Colman, Keith L. Ligon, Patrick Y. Wen,Timothy F. Cloughesy, Ingo K. Mellinghoff,Nicholas A. Butowski, Jennie W. Taylor, Jennifer L. Clarke,Susan M. Chang, Mitchel S. Berger, Annette M. Molinaro,Gerald M. Maggiora, Sen Peng, Sara Nasser,Winnie S. Liang, Jeffrey M. Trent, Michael E. Berens,John D. Carpten, David W. Craig, and Michael D. PradosSee related commentary, p. 256
306 Muscadine Grape Skin Extract (MPX) in Men withBiochemically Recurrent Prostate Cancer: ARandomized, Multicenter, Placebo-ControlledClinical TrialChanning J. Paller, Xian C. Zhou, Elisabeth I. Heath,Mary-Ellen Taplin, Tina Mayer, Mark N. Stein,Glenn J. Bubley, Roberto Pili, Tamaro Hudson,Radhika Kakarla, Muneer M. Abbas, Nicole M. Anders,Donna Dowling, Serina King, Ashley B. Bruns,William D. Wagner, Charles G. Drake,Emmanuel S. Antonarakis, Mario A. Eisenberger,Samuel R. Denmeade, Michelle A. Rudek, Gary L. Rosner,and Michael A. Carducci
316 A Randomized, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy andSafety of Monotherapy Ontuxizumab (MORAb-004) Plus Best Supportive Care in Patients withChemorefractory Metastatic Colorectal CancerAxel Grothey, Jonathan R. Strosberg, Lindsay A. Renfro,Herbert I. Hurwitz, John L. Marshall, Howard Safran,Michael J. Guarino, George P. Kim, J.R. Hecht,Susan C. Weil, John Heyburn, Wenquan Wang,Charles Schweizer, Daniel J. O'Shannessy, andLuis Alberto Diaz Jr
PERSONALIZED MEDICINE AND IMAGING
326 Location of Mutation in BRCA2 Gene andSurvival in Patients with Ovarian CancerS. Intidhar Labidi-Galy, Timoth�ee Olivier,Manuel Rodrigues, Domenico Ferraioli, Olfa Derbel,Alexandre Bodmer, Patrick Petignat, Beata Rak,Nicolas Chopin, Olivier Tredan, Pierre-Etienne Heudel,Sarah Stuckelberger, Pierre Meeus, Patrick Meraldi,Valeria Viassolo, Aur�elie Ayme, Pierre O. Chappuis,Marc-Henri Stern, Claude Houdayer,Dominique Stoppa-Lyonnet, Adrien Buisson,Lisa Golmard, Val�erie Bonadona, andIsabelle Ray-Coquard
334 Effects of Co-occurring Genomic Alterations onOutcomes in Patients with KRAS-Mutant Non–Small Cell Lung CancerKathryn C. Arbour, Emmett Jordan, Hyunjae Ryan Kim,Jordan Dienstag, Helena A. Yu, Francisco Sanchez-Vega,Piro Lito, Michael Berger, David B. Solit,MatthewHellmann, Mark G. Kris, Charles M. Rudin, Ai Ni,Maria Arcila, Marc Ladanyi, and Gregory J. Riely
January 15, 2018 � Volume 24 � Number 2
Clinical Cancer Research
Table ofContents
iv
on May 6, 2019. © 2018 American Association for Cancer Research. clincancerres.aacrjournals.org Downloaded from
341 RAD50 Expression Is Associated with PoorClinical Outcomes after Radiotherapy forResected Non–small Cell Lung CancerYifan Wang, Jayanthi Gudikote, Uma Giri, Jun Yan,Weiye Deng, Rui Ye, Wen Jiang, Nan Li, Brian P. Hobbs,Jing Wang, Stephen G. Swisher, Junya Fujimoto,Ignacio I. Wistuba, Ritsuko Komaki, John V. Heymach,and Steven H. Lin
351 Pancreatic Ductal Adenocarcinoma SubtypingUsing the Biomarkers Hepatocyte NuclearFactor-1A and Cytokeratin-81 Correlates withOutcome and Treatment ResponseAlexander Muckenhuber, Anne Katrin Berger,Anna Melissa Schlitter, Katja Steiger, Bj€orn Konukiewitz,Andreas Trumpp, Roland Eils, Jens Werner,Helmut Friess, Irene Esposito, G€unter Kl€oppel,G€uralp O. Ceyhan, Moritz Jesinghaus, Carsten Denkert,Marcus Bahra, Albrecht Stenzinger, Martin R. Sprick,Dirk J€ager, Christoph Springfeld, and Wilko Weichert
CANCER THERAPY: PRECLINICAL
360 Venetoclax Is Effective in Small-Cell LungCancers with High BCL-2 ExpressionTimothy L. Lochmann, Konstantinos V. Floros,Mitra Naseri, KristaM. Powell, Wade Cook, Ryan J.March,Giovanna T. Stein, Patricia Greninger, Yuki Kato Maves,Laura R. Saunders, Scott J. Dylla, Carlotta Costa,Sosipatros A. Boikos, Joel D. Leverson, Andrew J. Souers,Geoffrey W. Krystal, Hisashi Harada, Cyril H. Benes, andAnthony C. Faber
370 Allogeneic Human Double Negative T Cells as aNovel Immunotherapy for Acute MyeloidLeukemia and Its Underlying MechanismsJongBok Lee, Mark D. Minden, Weihsu C. Chen,Elena Streck, Branson Chen, Hyeonjeong Kang,Andrea Arruda, Dalam Ly, Sandy D. Der, Sohyeong Kang,Paulina Achita, Cheryl D'Souza, Yueyang Li,Richard W. Childs, John E. Dick, and Li Zhang
383 Inhibition of ID1–BMPR2 Intrinsic SignalingSensitizes Glioma Stem Cells to DifferentiationTherapyXiong Jin, Xun Jin, Leo J.Y. Kim, Deobrat Dixit,Hee-Young Jeon, Eun-Jung Kim, Jun-Kyum Kim,Seon Yong Lee, Jinlong Yin, Jeremy N. Rich, andHyunggee Kim
395 Dual mTOR Kinase Inhibitor MLN0128Sensitizes HRþ/HER2þ Breast Cancer Patient-Derived Xenografts to Trastuzumab orFulvestrantPei-Yin Hsu, Victoria Shang Wu, Noriko Kanaya,Karineh Petrossian, Hang-Kai Hsu, Duc Nguyen,Daniel Schmolze, Masaya Kai, Chun-Yu Liu, Hannah Lu,Peiguo Chu, Courtney A. Vito, Laura Kruper,Joanne Mortimer, and Shiuan Chen
BIOLOGY OF HUMAN TUMORS
407 Low PD-1 Expression in Cytotoxic CD8þ
Tumor-Infiltrating Lymphocytes Confers anImmune-Privileged Tissue Microenvironmentin NSCLC with a Prognostic and PredictiveValueGiulia Mazzaschi, Denise Madeddu, Angela Falco,Giovanni Bocchialini, Matteo Goldoni, Francesco Sogni,Giovanna Armani, Costanza Annamaria Lagrasta,Bruno Lorusso, Chiara Mangiaracina, Rocchina Vilella,Caterina Frati, Roberta Alfieri, Luca Ampollini,Michele Veneziani, EnricoMaria Silini, Andrea Ardizzoni,Konrad Urbanek, Franco Aversa, Federico Quaini, andMarcello Tiseo
420 Vimentin Is Required for Lung AdenocarcinomaMetastasis via Heterotypic Tumor Cell–Cancer-Associated Fibroblast Interactions duringCollective InvasionAlessandra M. Richardson, Lauren S. Havel,Allyson E. Koyen, Jessica M. Konen, John Shupe,W.G. Wiles, IV W. David Martin, Hans E. Grossniklaus,Gabriel Sica, Melissa Gilbert-Ross, and Adam I. Marcus
433 Monoclonal Antibodies Directed againstCadherin RGD Exhibit Therapeutic Activityagainst Melanoma and Colorectal CancerMetastasisRub�en A. Bartolom�e, Carmen Aizpurua, Marta Ja�en,Sofía Torres, Eva Calvi~no, Juan I. Imbaud, andJ. Ignacio CasalSee related commentary, p. 253
445 Inhibition of REDD1 Sensitizes BladderUrothelial Carcinoma to Paclitaxel byInhibiting AutophagyQinghai Zeng, Jianye Liu, Peiguo Cao, Jingjing Li,Xiaoming Liu, Xiaojun Fan, Ling Liu, Yan Cheng,Wei Xiong, Jigang Li, Hao Bo, Yuxing Zhu, Fei Yang,Jun Hu, Ming Zhou, Yanhong Zhou, Qiong Zou,Jianda Zhou, and Ke Cao
460 CD31 Expression Determines Redox Statusand Chemoresistance in Human AngiosarcomasVivek Venkataramani, Stefan K€uffer,Kenneth C.P. Cheung, Xuejun Jiang, Lorenz Tr€umper,Gerald G. Wulf, and Philipp Str€obel
474 Global Metabolic Profiling Identifies a PivotalRole of Proline and Hydroxyproline Metabolismin Supporting Hypoxic Response inHepatocellular CarcinomaLing Tang, Jun Zeng, Pengyu Geng, Chengnan Fang,Yang Wang, Mingju Sun, Changsong Wang, Jiao Wang,Peiyuan Yin, Chunxiu Hu, Lei Guo, Jane Yu, Peng Gao,Enyou Li, Zhengping Zhuang, Guowang Xu, andYang Liu
Table of Contents
v
on May 6, 2019. © 2018 American Association for Cancer Research. clincancerres.aacrjournals.org Downloaded from
486 Functional Role of a Novel Long NoncodingRNA TTN-AS1 in Esophageal Squamous CellCarcinoma Progression and MetastasisChenyu Lin, Shengnan Zhang, Ying Wang,Yuanshu Wang, Edouard Nice, Changying Guo,Erhao Zhang, Liting Yu, Mengwei Li, Chen Liu,Lirong Hu, Jingchao Hao, Weiyan Qi, andHanmei Xu
CORRECTIONS
499 Correction: Prevention of Colitis and Colitis-Associated Colorectal Cancer by a NovelPolypharmacological Histone DeacetylaseInhibitor
500 Correction: Phase Ib/II Study of the Safety andEfficacy of Combination TherapywithMultikinaseVEGF Inhibitor Pazopanib and MEK InhibitorTrametinib In Advanced Soft Tissue Sarcoma
AC icon indicates AuthorChoice
For more information please visit www.aacrjournals.org
ABOUT THE COVER
The cover shows a section of the lung from a patient affected by adenocarcinoma. Doubleimmunofluorescence staining illustrating cytotoxic tumor-infiltrating lymphocytes (TIL)carrying granzyme B (green) to hinder the invasion of the bronchial lumen by cytokeratinpositive (red) cancer cells. For details, see the article by Mazzaschi and colleagues onpage 407 of this issue.
Table of Contents
vi
on May 6, 2019. © 2018 American Association for Cancer Research. clincancerres.aacrjournals.org Downloaded from
2018;24:251-501. Clin Cancer Res 24 (2)
Updated version
http://clincancerres.aacrjournals.org/content/24/2
Access the most recent version of this article at:
E-mail alerts related to this article or journal.Sign up to receive free email-alerts
Subscriptions
Reprints and
To order reprints of this article or to subscribe to the journal, contact the AACR Publications Department at
Permissions
Rightslink site. Click on "Request Permissions" which will take you to the Copyright Clearance Center's (CCC)
.http://clincancerres.aacrjournals.org/content/24/2To request permission to re-use all or part of this article, use this link
on May 6, 2019. © 2018 American Association for Cancer Research. clincancerres.aacrjournals.org Downloaded from